SOCIUM Inc

ActiveAI-native

SOCIUM is an AI-powered drug discovery and development company focused on first-in-class small molecules.

What it does

SOCIUM is an AI-powered drug discovery and development company focused on first-in-class small molecules. The company currently has a development portfolio of over 23 diseases, including oncology and rare diseases. The company replaces multiple steps in the traditional drug discovery process with an in-silico system using our cutting edge algorithm, established a system to identify the drug discovery target in a few months. By taking a systems biology approach using our Augmented intelligence and Machine Learning – instead of hypothesizing the mechanism of a disease and focusing on only a few related compounds, we profile the entire disease by analyzing various OMICS data.

Its site says now · captured 2026-08-23

SOCIUM is a drug discovery venture company with the corporate vision of

Next to it in Healthcare and bio · AI-powered drug discovery and development

  • CardiaTec BiosciencesPlug and Play

    CardiaTec is a digital biotechnology venture combining the power of AI and expert talent to redesign cardiovascular drug discovery.

  • OwkinPlug and Play

    Owkin combines life-science and machine learning expertise to make drug development and clinical trial design more targeted and more cost effective. Owkin's machine learning algorithms create models that predict disease evolution and treatment outcomes.

  • RevorfPlug and Play

    Revorf is a medical technology and drug discovery platform.

  • サスメド株式会社Plug and Play

    Sustainable Medicine AI automatic analysis system Development company.

  • Numerion LabsY Combinator W15

    Artificial intelligence for drug discovery.

  • モジュラス株式会社Plug and Play

    Modulus Discovery is a preclinical-stage technology-driven drug discovery firm.

  • OmniSciencePlug and Play

    OmniScience is a leading AI organization advancing life science missions through unparalleled expertise in biology and data science.

  • Verge GenomicsY Combinator S15

    We use human data and AI to develop better drugs faster.